Virginia Regulatory Town Hall List Comments

Virginia Department of Health

State Board of Health

Prescription Drug Price Transparency Regulation [Under Development] [12 VAC 5 ‑ 219]

Public Comment Forum

On this Action:

Promulgation of New Regulation to Implement Chapter 304 of the 2021 Acts of Assembly, Special Session I

Emergency/NOIRA Stage - View the regulatory documents

CLOSED Opened on 1/17/2022 and Ended on 2/16/2022

More about public comment forums and policies

View all comments

4 comments

Comment Title	Commenter	Date Oldest First
PhRMA Comments re Chapter 219 Prescription Drug Price Transparency Regulation	PhRMA	2/16/22 5:15 pm
Request Clarification of Manufacturer and Reporting Entity.	Pharma Solutions USA, Inc., Sumeet Singh CEO & Deneen Fumich, Director	2/16/22 11:08 am
Suggestion to exempt Contract Manufacturing Organizations from requirement	Gil Roth, Pharma & Biophama Outsourcing Association (PBOA)	2/15/22 5:04 pm
Recommend explicitly excl CMOs [and similar org] who manufacture but do not market or set prices	Catalent Pharma Solutions, Inc.	2/14/22 6:21 pm

Trouble posting comments? These pages have been tested with multiple versions of all the major browsers. If you have trouble: (1) try another computer if you have access to one, (2) try another browser if your computer has one installed (3) contact Town Hall support staff for assistance.